<x-layout title="How SCD Can Be Treated and Managed">

    <!-- Treated & Manage Start -->

    <div class="help-area pt-10 pb-40 ptb-sm-60">

        <div class="pb-50">
            <div class="container">

                <h4 class="pt-10 pb-20 text-danger text-center">How SCD Can Be Treated and Managed</h4>


                <div class="accordion pt-40 px-4" id="ghanaSCDAccordion">

                    <!-- 1 -->
                    <div class="accordion-item">
                        <h2 class="accordion-header" id="heading1">
                            <button class="accordion-button collapsed text-primary fs-5 fw-bold" type="button"
                                    data-bs-toggle="collapse" data-bs-target="#collapse1" aria-expanded="false" aria-controls="collapse1">
                                1. There are proven strategies for managing and treating sickle cell disease in Ghana
                            </button>
                        </h2>
                        <div id="collapse1" class="accordion-collapse collapse" aria-labelledby="heading1" data-bs-parent="#ghanaSCDAccordion">
                            <div class="accordion-body">
                                <p class="text-black mb-1">• Over the past three decades, each one of the following strategies has been implemented in Ghana.</p>
                                <p class="text-black mb-1">• Some have been implemented more broadly and consistently than others.</p>
                                <p class="text-black mb-1">• When we are able to effectively scale up the implementation of these proven strategies, we will be able to prolong lives and significantly reduce preventable pain and suffering for our nation’s Sickle Cell Warriors and their families.</p>

                                <div class="mt-2 mb-2" style="margin-left: 1.5em;">
                                    <p class="text-black mb-1">1. Prevention and early diagnosis of SCD</p>
                                    <p class="text-black mb-1">2. Newborn screening (NBS) and early infant diagnosis (EID)</p>
                                    <p class="text-black mb-1">3. Premarital counseling</p>
                                    <p class="text-black mb-1">4. Maternal carrier testing</p>
                                    <p class="text-black mb-1">5. Prenatal diagnosis</p>
                                    <p class="text-black mb-1">6. Supportive management</p>
                                    <p class="text-black mb-1">7. Pain Management</p>
                                    <p class="text-black mb-1">8. Infection prevention</p>
                                    <p class="text-black mb-1">9. Hydroxyurea</p>
                                    <p class="text-black mb-1">10. Folic acid supplementation</p>
                                    <p class="text-black mb-1">11. Blood transfusion</p>
                                    <p class="text-black mb-1">12. Screening for stroke</p>
                                    <p class="text-black mb-1">13. Psychosocial care</p>
                                    <p class="text-black mb-1">14. Outpatient care</p>
                                    <p class="text-black mb-1">15. Health education on SCD</p>
                                    <p class="text-black mb-1">16. Curative management</p>
                                </div>

                                <p class="text-black mb-1">
                                    • <a href="https://www.sciencedirect.com/science/article/pii/S0037196323000598" class="text-primary" target="_blank">
                                        Current challenges and new approaches to implementing optimal management of sickle cell disease in sub-Saharan Africa
                                    </a>
                                </p>
                            </div>
                        </div>
                    </div>

                    <!-- 2 -->
                    <div class="accordion-item">
                        <h2 class="accordion-header" id="heading2">
                            <button class="accordion-button collapsed text-primary fs-5 fw-bold" type="button"
                                    data-bs-toggle="collapse" data-bs-target="#collapse2" aria-expanded="false" aria-controls="collapse2">
                                2. Ghana has had 30 years of SCD TREATMENT groundwork to build upon
                            </button>
                        </h2>
                        <div id="collapse2" class="accordion-collapse collapse" aria-labelledby="heading2" data-bs-parent="#ghanaSCDAccordion">
                            <div class="accordion-body">
                                <p class="text-black mb-1">• From 1992 to 2022, Prof. Kwaku Ohene-Frempong, MD, with the support of international partners and colleagues in Ghana, provided national and global leadership for SCD detection, treatment, and management. Sadly, Prof. passed away in 2022.</p>
                                <p class="text-black mb-1">• Since 2023, the Ghana Foundation for Sickle Gene Action (GF-SGA) has worked to fill part of the void left by Prof. Ohene-Frempong, aiming to restore lost programming and build upon the groundwork he laid.</p>
                                <p class="text-black mb-1">• In August 2023, one year after his passing, the SPARCo Standards of Care for SCD in Sub-Saharan Africa were released, providing a unifying call to action to implement these guidelines nationwide.</p>

                                <p class="text-black mb-1 fw-bold">See: Our Groundwork</p>
                                <div style="margin-left: 1.5em;">
                                    <p class="text-black mb-1">1. The Sickle Cell Foundation of Ghana (SCFG)</p>
                                    <p class="text-black mb-1">2. Newborn Screening (NBS) and Sickle Cell Clinics</p>
                                    <p class="text-black mb-1">3. Hydroxyurea (HU)</p>
                                    <p class="text-black mb-1">4. Global Partnerships and Collaborations</p>
                                    <p class="text-black mb-1">5. Centers of Excellence (COEs)</p>
                                    <p class="text-black mb-1">6. The Kumasi Center for Sickle Cell Disease and Blood</p>
                                    <p class="text-black mb-1">7. A Model for Compassion, Commitment, Collaboration, Cooperation, and Collegiality</p>
                                    <p class="text-black mb-1">8. The SPARCo Treatment Guidelines</p>
                                </div>
                            </div>
                        </div>
                    </div>

                    <!-- 3 -->
                    <div class="accordion-item">
                        <h2 class="accordion-header" id="heading3">
                            <button class="accordion-button collapsed text-primary fs-5 fw-bold" type="button"
                                    data-bs-toggle="collapse" data-bs-target="#collapse3" aria-expanded="false" aria-controls="collapse3">
                                3. As of August 2023, AFRICA has the landmark SPARCo “Treatment Guidelines”
                            </button>
                        </h2>
                        <div id="collapse3" class="accordion-collapse collapse" aria-labelledby="heading3" data-bs-parent="#ghanaSCDAccordion">
                            <div class="accordion-body">
                                <p class="text-black mb-1">We support these treatment guidelines, designed to meet our specific needs.</p>
                                <p class="text-black mb-1">• The SPARCo Standards of Care for Sickle Cell Disease in Sub-Saharan Africa</p>
                                <div style="margin-left: 1.5em;">
                                    <p class="text-black mb-1">- The Last Referral Hospital Standard Version, August 2023</p>
                                    <p class="text-black mb-1">- The Home Based Version, September 2023</p>
                                </div>
                                <p class="text-black mb-1">• They are unique because they offer recommendations for different levels of care, unlike traditional guidelines focused on tertiary care only.</p>

                                <p class="text-black mb-1 fw-bold">We thank each individual involved:</p>
                                <div style="margin-left: 1.5em;">
                                    <p class="text-black mb-1">• Contributors, reviewers, administrative and technical staff members, and funders</p>
                                    <p class="text-black mb-1">• The SickleInAfrica Consortium, including members of SPARCO and SPAN</p>
                                    <p class="text-black mb-1">• The Sickle Africa Data Coordinating Center (SADaCC)</p>
                                    <p class="text-black mb-1">• Ghana’s Prof. Ohene-Frempong, who led the group’s work and developed the innovative multi-level approach</p>
                                </div>

                                <p class="text-black mb-1 fw-bold">We appreciate their effort to empower healthcare professionals:</p>
                                <p class="text-black mb-1">• Guidelines were developed using both African and non-African sources to ensure suitability for sub-Saharan conditions.</p>

                                <p class="text-black mb-1 fw-bold">Intended audience:</p>
                                <p class="text-black mb-1">• Those providing emergency or ongoing care for SCD patients at last referral hospitals in sub-Saharan Africa.</p>

                                <p class="text-black mb-1 fw-bold">Recommendations include:</p>
                                <div style="margin-left: 1.5em;">
                                    <p class="text-black mb-1">• Diagnosis</p>
                                    <p class="text-black mb-1">• Health Maintenance and Preventive Therapy</p>
                                    <p class="text-black mb-1">• Screening for Specific Complications</p>
                                    <p class="text-black mb-1">• Management of Acute Complications</p>
                                    <p class="text-black mb-1">• Management of Chronic Complications</p>
                                    <p class="text-black mb-1">• Special Protocols: Hydroxyurea use and blood transfusions</p>
                                </div>

                                <p class="text-black mb-1">
                                    • Click here to download:
                                    <a href="#" class="text-primary">SPARCo_SoC_SCD_GuidelinesR_Aug2023.pdf</a>,
                                    <a href="#" class="text-primary">SPARCo_SoC_Homebased_version.pdf</a>
                                </p>
                            </div>
                        </div>
                    </div>

                    <!-- 4 -->
                    <div class="accordion-item">
                        <h2 class="accordion-header" id="heading4">
                            <button class="accordion-button collapsed text-primary fs-5 fw-bold" type="button"
                                    data-bs-toggle="collapse" data-bs-target="#collapse4" aria-expanded="false" aria-controls="collapse4">
                                4. What Ghana needs is political will and adequate funding
                            </button>
                        </h2>
                        <div id="collapse4" class="accordion-collapse collapse" aria-labelledby="heading4" data-bs-parent="#ghanaSCDAccordion">
                            <div class="accordion-body">
                                <p class="text-black mb-1">• We know what needs to be done and what our challenges are.</p>
                                <p class="text-black mb-1">• We need adequate funding to overcome these documented challenges, given Ghana’s high incidence of SCD.</p>
                                <p class="text-black mb-1">• The government must treat SCD as a public health challenge, not a private matter.</p>
                                <p class="text-black mb-1">• Past groundwork was supported by government funding, external grants, and partnerships, but sustainability has been lacking.</p>
                                <p class="text-black mb-1">• We urgently need effective funding strategies and reliable governmental support.</p>
                            </div>
                        </div>
                    </div>

                    <!-- 5 -->
                    <div class="accordion-item">
                        <h2 class="accordion-header" id="heading5">
                            <button class="accordion-button collapsed text-primary fs-5 fw-bold" type="button"
                                    data-bs-toggle="collapse" data-bs-target="#collapse5" aria-expanded="false" aria-controls="collapse5">
                                5. We can accomplish a lot with broad-based support
                            </button>
                        </h2>
                        <div id="collapse5" class="accordion-collapse collapse" aria-labelledby="heading5" data-bs-parent="#ghanaSCDAccordion">
                            <div class="accordion-body">
                                <p class="text-black mb-1">• Much is required to manage and treat SCD, including patient education, medical resources, trained clinicians, and insurance.</p>
                                <p class="text-black mb-1">• Immediate priorities include restoring newborn screening, affordable hydroxyurea access, and stroke prevention programs.</p>
                                <p class="text-black mb-1">• We will work with the government to restore 22 discontinued newborn screening sites, fulfill NHIS promises for hydroxyurea, and scale up transcranial doppler screening access.</p>
                            </div>
                        </div>
                    </div>

                </div>


            </div>

        </div>

    </div>


    <!-- Treated & Manage End -->



</x-layout>
